HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of alprazolam on cortical activity and tremors in patients with essential tremor.

AbstractBACKGROUND:
Essential tremor (ET) is characterised by postural and action tremors with a frequency of 4-12 Hz. Previous studies suggest that the tremor activity originates in the cerebello-thalamocortical pathways. Alprazolam is a short-acting benzodiazepine that attenuates tremors in ET. The mechanisms that mediate the therapeutic action of alprazolam are unknown; however, in healthy subjects, benzodiazepines increase cortical beta activity. In this study, we investigated the effect of alprazolam both on beta and tremor-related cortical activity and on alterations in tremor presentation in ET patients. Therefore, we characterised the dynamics of tremor and cortical activity in ET patients after alprazolam intake.
METHODS:
We recorded hand tremors and contralateral cortical activity in four recordings before and after a single dose of alprazolam. We then computed the changes in tremors, cortico-muscular coherence, and cortical activity at the tremor frequency and in the beta band.
RESULTS:
Alprazolam significantly attenuated tremors (EMG: 76.2 ± 22.68%), decreased cortical activity in the tremor frequency range and increased cortical beta activity in all patients (P<0.05). At the same time, the cortico-muscular coherence at the tremor frequency became non-significant (P<0.05). We also found a significant correlation (r = 0.757, P<0.001) between the reduction in tremor severity and the increased ratio of cortical activity in the beta band to the activity observed in the tremor frequency range.
CONCLUSIONS:
This study provides the first quantitative analysis of tremor reduction following alprazolam intake. We observed that the tremor severity decreased in association with an increased ratio of beta to tremor-related cortical activity. We hypothesise that the increase in cortical beta activity may act as a blocking mechanism and may dampen the pathological oscillatory activity, which in turn attenuates the observed tremor.
AuthorsJaime Ibáñez, Jesús González de la Aleja, Juan A Gallego, Juan P Romero, Rosana A Saíz-Díaz, Julián Benito-León, Eduardo Rocon
JournalPloS one (PLoS One) Vol. 9 Issue 3 Pg. e93159 ( 2014) ISSN: 1932-6203 [Electronic] United States
PMID24667763 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Alprazolam
Topics
  • Alprazolam (pharmacology, therapeutic use)
  • Brain (drug effects, physiopathology)
  • Electromyography
  • Essential Tremor (complications, drug therapy, physiopathology)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Muscles (drug effects, physiopathology)
  • Tremor (complications, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: